Science Explorer Back to mapMap
Discussion
Researcher · Krankenhaus Nordwest · Germany

Akin Atmaca

Akin Atmaca publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Lung Cancer Research Studies.

OpenAlex
World rank
#721,181
of 7,710,434 ranked researchers
Rank in Germany
#35,550
of 364,343
Works
114
Citations
6.4k
Citations per work
55.7
h-index
30
i10-index 46Top 11% in Oncology
Akin Atmaca

What does Akin Atmaca research?

Akin Atmaca's work is mostly in Medicine (64%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (10%).

Health Sciences: 73 works · 63.6% of their workMedicine: 73 works · 63.6% of their workOncology: 43 works · 37.4% of their workPulmonary and Respiratory Medicine: 26 works · 22.4% of their workSurgery: 4 works · 3.8% of their workLife Sciences: 27 works · 24.0% of their workBiochemistry, Genetics and Molecular Biology: 16 works · 13.9% of their workMolecular Biology: 12 works · 10.8% of their workCancer Research: 4 works · 3.1% of their workImmunology and Microbiology: 12 works · 10.1% of their workImmunology: 12 works · 10.1% of their workEverything else: 14 works · 12.4% of their workTHEIR WORKAkin Atmaca114works
Life Sciences24%Health Sciences64%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine7363.6%
    1. Biochemistry, Genetics and Molecular Biology1613.9%
    2. Immunology and Microbiology1210.1%
  3. Everything else1412.4%
  1. 1Oncology37% of their works
  2. 2Pulmonary and Respiratory Medicine22% of their works
  3. 3Molecular Biology11% of their works
  4. 4Immunology10% of their works
  5. 5Surgery4% of their works
  6. 6Cancer Research3% of their works

Research topics

Which keywords describe Akin Atmaca's research?

The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, Immunotherapy, ALK Inhibitors, EGFR Mutations, Cancer Immunotherapy and Immune Checkpoint Blockade.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Chemotherapy624 topics
  2. Clinical Trials592 topics
  3. Targeted Therapy592 topics
  4. Immunotherapy372 topics
  5. ALK Inhibitors321 topic
  6. EGFR Mutations321 topic
  7. Cancer Immunotherapy282 topics
  8. Immune Checkpoint Blockade281 topic
  9. PD-1 and PD-L1281 topic
  10. Genomic Profiles271 topic
  11. Small-Cell Lung Cancer271 topic
  12. Adjuvant Therapy242 topics
  13. Dendritic Cells181 topic
  14. Immunity181 topic
  15. Endoscopic Resection151 topic
  16. Gastric Cancer151 topic
  17. Cetuximab111 topic
  18. KRAS Mutations111 topic
  19. CAR T Cells101 topic
  20. Chimeric Antigen Receptor101 topic
  21. CT Screening91 topic
  22. Lung Cancer91 topic

Where does Akin Atmaca work?

Akin Atmaca's main affiliation in the publication record is Krankenhaus Nordwest, Germany.

How many publications and citations does Akin Atmaca have?

OpenAlex counts 114 works and 6,353 citations for Akin Atmaca, an h-index of 30, ranking #721,181 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Akin Atmaca. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.